medigraphic.com
ISSN 2594-1518 (Electronic)
ISSN 1405-0099 (Print)

2011, Number 2

<< Back Next >>

Cir Gen 2011; 33 (2)

Assessment of morbidity of central neck compartment dissection in papillary thyroid cancer

Vásquez CS, Granados GM, Luna OK, Carrillo JF, Del Villar GK, García MR, Leyva GO, Palomeque LA, Lavín LA

Language: Spanish
References: 17
Page: 111-114
PDF size: 64.68 Kb.


ABSTRACT

Objective: To assess hypocalcemia and injury to the recurrent laryngeal nerve secondary to total thyroidectomy plus central compartment dissection in papillary thyroid cancer.
Setting: National Institute of Cancerology, Mexico
Design: Descriptive, observational, retrospective, prospective, longitudinal clinical study.
Statistical analysis: Percentages as summary measure for qualitative variables.
Patients and methods: Twenty-four patients with diagnosis of papillary thyroid cancer (PTC), established by cytology and histopathology, subjected to central dissection of the neck as part of the initial surgical treatment with a follow-up of at least 6 months. Assessed variables were: surgical time, trans-operative bleeding, vocal cords mobility, assessed through direct laryngoscopy pre- and postoperatively, hypocalcemia and hypothyroidism, re-intervention, and number of dissected ganglia.
Results: Twenty four patients, 16 with thyroid-confined disease, and 8 with neck involvement. Average surgical time of 2 to 4.30 hours, mean of 2.2, bleeding of 100 to 400 ml, mean of 196 ml. One patient with transient hypocalcemia, nill patients with permanent hypocalcemia confirmed with PHT testing, nill Recurrent laryngeal nerve (NLRL) injuries, nill re-interventions; the number of dissected ganglia was 7 to 16.
Conclusions: Morbidity of total thyroidectomy plus dissection of the central compartment consisted of transient hypocalcemia (4.1%). Neither recurrent laryngeal nerve injury nor hypoparathyroidism occurred.


REFERENCES

  1. Sherman SI. Thyroid carcinoma. Lancet 2003; 361: 501-511.

  2. Rubello D, Saladini G, Carpi A, Casara D. Nuclear medicine imaging procedures in differentiated thyroid carcinoma patients with negative iodine scan. Biommed Pharmacother 2000; 54: 337-44.

  3. Aras G, Gultekin SS, Küçük NO, Genç Y. Is thyroglobulin the stronger indicator for progressive disease than the other conventional factors in same age patient group with differentiated thyroid cancer? Nucl Med Commun 2007; 28: 907-913.

  4. Rubello D, O’Doherty MJ. Sentinel lymph node biopsy in differentiated thyroid cancer: standard of care or experimental tool? Nucl Med Communc 2006; 27: 833-835.

  5. Küçük NO, Külak HA, Aras G. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results. Ann Nucl Med 2006; 20: 393-397.

  6. Qubain SW. Nakano S. Baba M, Takao S, Ailou T. Distribution of lymph node micrometastasis in pN0 well differentiated thyroid carcinoma. Surgery 2002; 131: 249-256.

  7. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998; 85: 252-254.

  8. Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M, Defechereux T. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998; 383: 167-169.

  9. Pereira JA, Jimeno J. Miquel J, Iglesias M, Munné A, Sancho JJ, et al. Nodal yield, morbidity and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005, 138: 1095-1101.

  10. Shindo M. Wu JC, Park EE, Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2006; 132: 650-654.

  11. Wada N, Duh QY Sugino K, Kawasaki H, Kameyama K, Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003; 237: 339-407.

  12. Scheumann GF, Gimm O. Wegener G, Hundeshagen H, Drallen H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994; 18: 559-567.

  13. White MD, Gauger PG, Doherty GH. Central lymph node dissection in differentiated thyroid cancer. World J Surg 2007; 31: 895-904.

  14. Shaha AR. Controversies about the central compartment in thyroid cancer. Editorial Eur Arch Otorhinolaryngol 2011; 268: 1097-1099.

  15. Hughes CJ. Shaha AR. Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996; 18: 127-132.

  16. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002; 26: 22-28.

  17. Hurtado-López LM, Basurto-Kuba E, Garza-Flores JH, Pulido-Cejudo A. Génesis de la hipocalcemia post-tiroidectomía. Cir Gen 1988; 20(2): 106-110.




2020     |     www.medigraphic.com